2022 ´ëÇÑÇ÷¾×ÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2022-11-11±³À°ÀÏÀÚ : 2022-11-11
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ :
2022 ´ëÇÑÇ÷¾×ÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
±¤ÁÖ±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü¹®ÀÇ ₩50,000, Àü°øÀÇ, °£È£»ç ¹× ±âŸ ₩20,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 A·ë 10:00~11:00 Past and future of WHO classification of lymphoid neoplasm °í¿µÇý(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-11 A·ë 11:00~12:00 Distinction of live immune cells by fluorescent probe À念ÅÂ(Æ÷Ç×°ø´ë)
±³À°½Ã°£ 11-11 C·ë 13:00~13:40 Emerging trends and Korean real-world of CAT(cancer-associated thrombosis) ÀÌÁöÇö(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 11-11 C·ë 13:40~14:20 Thrombosis in ITP(immune thrombocytopenic purpura) ±è»ó¾Æ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 C·ë 14:20~15:00 Alternatives to blood transfusion and prophylactic transfusion ±è°æÇÏ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 11-11 B·ë 15:30~16:00 Clinical, pathological, and genomic features of follicular helper T-cell derived lymphomas À±»óÀº(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-11 B·ë 16:00~16:30 Novel therapeutic agents for T-cell lymphomas Á¶Çü¿ì(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-11 B·ë 16:30~17:00 The role of allogeneic stem cell transplantation in T-cell lymphomas Àü¿µ¿ì(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-11 B·ë 17:00~17:30 Current treatment strategies for extranodal NK/T cell lymphoma Á¶Àçö(¿ï»êÀÇ´ë)